Trial Profile
Factors for poor activated partial thromboplastin time control after dabigatran administration
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Mar 2018
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary)
- Indications Venous thromboembolism
- Focus Pharmacodynamics; Pharmacokinetics; Therapeutic Use
- 18 Mar 2018 New trial record